PP
HAE icon

Paloma Partners’s Haemonetics HAE Stock Holding History

Paloma Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,746
Closed -$623K – 614
2024
Q3 		$623K Buy
+7,746
New +$626K 0.02% 558
2022
Q1 		– Sell
-6,000
Closed -$318K – 1958
2021
Q4 		$318K Buy
+6,000
New +$366K ﹤0.01% 1375
2021
Q2 		– Sell
-5,760
Closed -$640K – 1980
2021
Q1 		$640K Buy
+5,760
New +$713K 0.01% 960
2020
Q4 		– Sell
-10,868
Closed -$949K – 1867
2020
Q3 		$949K Sell
10,868
-80,369
-88% -$7.02M 0.02% 770
2020
Q2 		$8.17M Buy
+91,237
New +$9.22M 0.14% 143
2020
Q1 		– Sell
-25,617
Closed -$2.94M – 1568
2019
Q4 		$2.94M Buy
25,617
+10,246
+67% +$1.24M 0.04% 433
2019
Q3 		$1.94M Buy
+15,371
New +$1.95M 0.04% 443
2019
Q2 		– Sell
-9,530
Closed -$833K – 1922
2019
Q1 		$833K Buy
+9,530
New +$867K 0.02% 818
2018
Q4 		– Sell
-13,803
Closed -$1.58M – 1469
2018
Q3 		$1.58M Buy
+13,803
New +$1.43M 0.03% 554
2017
Q4 		– Sell
-4,714
Closed -$211K – 2042
2017
Q3 		$211K Buy
+4,714
New +$196K ﹤0.01% 1966
2015
Q4 		– Sell
-9,493
Closed -$306K – 1788
2015
Q3 		$306K Sell
9,493
-9,725
-51% -$366K 0.01% 1276
2015
Q2 		$795K Buy
+19,218
New +$810K 0.02% 872
2014
Q1 		– Sell
-25,611
Closed -$1.08M – 816
2013
Q4 		$1.08M Buy
+25,611
New +$1.05M 0.05% 367
2013
Q3 		– Sell
-5,613
Closed -$232K – 1035
2013
Q2 		$232K Buy
+5,613
New +$227K 0.01% 792

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Paloma Partners's HAE Position: Q4 2024 in Review

Paloma Partners sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 7,746 shares — an estimated $623K sold.

Paloma Partners first reported a position in HAE in Q2 2013 and held it in 14 quarters. The position peaked at $8.17M in Q2 2020. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.

  • Paloma Partners reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 7,746 Haemonetics shares in Q4 2024, an estimated $623K.
  • Paloma Partners first reported a position in Haemonetics in Q2 2013 and held it in 14 quarters.
  • Paloma Partners's Haemonetics position peaked at $8.17M in Q2 2020.
  • 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.